Precision Medicine

NIH All of Us Project Tops 270,000 Sign-ups and On Track to Enroll 1M Participants by 2024

2019-08-19T13:15:43-04:00

By Heather Landi, Fierce Healthcare | August 16, 2019 The National Institutes of Health-led All of Us precision medicine health research database project has enrolled 230,000 participants as of July 2019, with an additional 40,000 people registering on the website, according to researchers involved with the project. Of those participants, 175,000 [...]

NIH All of Us Project Tops 270,000 Sign-ups and On Track to Enroll 1M Participants by 20242019-08-19T13:15:43-04:00

FDA Partners with Syapse to Study Regulatory Use of Real-world Evidence

2019-08-19T13:11:09-04:00

By Mike Miliard, Healthcare IT News | August 15, 2019 The U.S. Food and Drug Administration's Oncology Center of Excellence is embarking on a multi-year research partnership with Syapse, the developer of precision medicine technology. The collaboration centers around how to better use of real-world evidence to support regulatory decisions. [...]

FDA Partners with Syapse to Study Regulatory Use of Real-world Evidence2019-08-19T13:11:09-04:00

Smart Wearables to Unlock the Next Level of Precision Medicine

2019-08-05T02:23:58-04:00

By Veronica Vartanova, MobiHealth News | August 2, 2019 Since their early days as wellness tools, these devices are now informing precision medicine initiatives and leading clinical studies. Veronika Vartanova is a mobility researcher at Iflexion, a software development company based in Denver, Colorado. She writes on the latest trends [...]

Smart Wearables to Unlock the Next Level of Precision Medicine2019-08-05T02:23:58-04:00

Half of ‘All of Us’ Participants Are Underrepresented Minorities, NIH Chief Says

2019-08-04T22:59:41-04:00

By Jessica Kim Cohen, Becker's Hospital Review | July 25, 2019 Francis Collins, MD, PhD, director of the National Institutes of Health, offered an update on the agency's All of Us Research Program during a hearing before a House subcommittee July 25. The All of Us Research Program, part of [...]

Half of ‘All of Us’ Participants Are Underrepresented Minorities, NIH Chief Says2019-08-04T22:59:41-04:00

How Best to Describe Precision Medicine Beyond Oncology? ‘It’s Complicated.’

2019-07-22T23:20:09-04:00

By Alaric Dearment, MedCity News | July 21, 2019 While well-developed in cancers, precision medicine's readiness for prime time beyond oncology varies markedly from disease to disease. But reimbursement remains a significant hurdle. More than a decade ago, the science fiction author William Gibson said, “The future is here – [...]

How Best to Describe Precision Medicine Beyond Oncology? ‘It’s Complicated.’2019-07-22T23:20:09-04:00

As Precision Medicine Grows, So Does the Importance of Clinical Trial Diversity

2019-07-08T03:56:47-04:00

By Alaric Debarment, MedCity News | July 7, 2019 Experts said the rise of cutting-edge new therapies highlighted disparities between clinical trial populations and the patients receiving new drugs. An FDA draft guidance earlier this month sought to address the issue. The idea of a drug having to undergo clinical [...]

As Precision Medicine Grows, So Does the Importance of Clinical Trial Diversity2019-07-08T03:56:47-04:00